000 UAW members at GM voting in favor.

and CRISPR Therapeutics was approved by the agency for the treatment for patients with sickle cell disease and thalassemia who are 12 years old and over.Expert joins CBS New York to discuss new sickle cell treatment Expert joins CBS New York to discuss new sickle cell treatment 02:46 Britains medicines regulator has authorized the worlds first gene therapy treatment for sickle cell disease.

Millions of people around the world.and is also more common in certain ethnic groups.In people with sickle cell which is particularly common in people with African or Caribbean heritage a genetic mutation causes the cells to become crescent-shaped.

Both sickle cell disease and thalassemia are caused by mistakes in the genes that carry hemoglobin.Southeast Asian and Middle Eastern heritage.

Britains regulator said its decision to authorize the gene therapy for sickle cell disease was based on a study done on 29 patients.

Patients typically require blood transfusions every few weeks.Many group members have shared their own encounters.

there were 207 recorded interactions.Any movement that makes that action uncomfortable for them will deter them.

There have been several documented instances reported this year.What were seeing is adaptive behavior.